Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 5/20 | 0.34 |
| ▸ | HCRTR2 | O43614 | 5/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 5/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5761936 | 0.85 | PTGER4 (0.40) | CAPN1HCRTR1HCRTR2PTGER4 | |
| SCHEMBL5762186 | 0.85 | CAPN1 (0.35) | CAPN1HCRTR1HCRTR2ATML3MBTL1 | |
| SCHEMBL5763606 | 0.82 | PTGER4 (0.37) | CAPN1HCRTR1HCRTR2PTGER4P2RX7 | |
| SCHEMBL5760403 | 0.79 | PTGER4 (0.38) | PTGER4 | |
| SCHEMBL5762382 | 0.79 | HCRTR1 (0.37) | CAPN1HCRTR1HCRTR2PTGER4P2RX7 | |
| SCHEMBL4373362 | 0.79 | PTGER4 (0.38) | CAPN1HCRTR1HCRTR2PTGER4 | |
| SCHEMBL5762444 | 0.77 | HCRTR1 (0.35) | CAPN1HCRTR1HCRTR2L3MBTL1PTGER4 | |
| SCHEMBL4378130 | 0.75 | PTGER4 (0.51) | PTGER4 | |
| SCHEMBL1377509 | 0.72 | P2RX7 (0.37) | HCRTR1HCRTR2PTGER4P2RX7 | |
| SCHEMBL5757536 | 0.71 | PTGER4 (0.46) | HCRTR1HCRTR2PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1631355-A1 | PIPERIDINYL PROSTAGLANDIN E ANALOGS | Allergan, Inc. (US) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004108215-A1 | PIPERIDINYL PROSTAGLANDIN E ANALOGS | ALLERGAN, INC. (US) | 2004-12-16 | — | — | WO | disclosed |